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Abstract. The 180-kD bullous pemphigoid autoantigen 
(BP180) is a component of the hemidesmosome, a cell- 
matrix connector. This protein is oriented in a type II 
fashion in the membrane of the hemidesmosome and is 
a hybrid collagen (classified as type XVII). We have an- 
alyzed the fate of various mutant BP180 molecules 
transfected into several different cell types. A protein, 
D1, lacking the collagen-like extracellular domains of 
BP180 polarizes normally in 804G epithelial cells and 
colocalizes with other hemidesmosomal components in 
the plane of the basal cell surface. However, deletion of 
a stretch of 36 amino acids located at the NH2 terminus 
of D1 induces an apical polarization of the protein (D1- 
36N) in the cell surface of 804G cells. Deletion of the 
27-amino acid noncollagenous extracellular domain 
that is located immediately after the membrane span- 
ning domain of BP180 results in a failure of D1-27C 
protein to codistribute with other hemidesmosomal 
components despite its basal localization in transfected 
804G cells. In FG cells, which lack their own BP180, 
transfected D1 protein localizes with the ot61~4 integrin 
heterodimer. In HT1080 cells, which do not possess 
BP180 or 64 integrin, D1 protein localizes with ot6131 in- 
tegrin while both the D1-27C and D1-36N proteins do 
not. Moreover, D1 protein coprecipitates with et6 inte- 
grin from extracts of HT1080 transfectants. Taken to- 
gether, these results suggest that the NH2-terminal do- 
main of BP180 determines polarization of BP180 while 
the noncollagenous extracellular domain of BP180 sta- 
bilizes its interactions with other hemidesmosomal 
components, such as e~6 integrin. Perturbation of this 
latter domain by human bullous pemphigoid autoanti- 
bodies may explain the loss of epidermal cell-dermis 
attachment that characterizes the BP disease. 
T 
HE skin provides protection from physical, chemi- 
cal, and biological trauma. Its outer surface is cov- 
ered by a stratified layer of epithelial cells that must 
be  firmly attached to the connective tissue  to maintain 
skin integrity. This adherence is, in part, mediated by cer- 
tain cell-matrix junctions called hemidesmosomes that in- 
tegrate the cytoskeleton of the cell with the extracellular 
matrix (Staehelin, 1974; Jones et al., 1994). A number of 
adhesion  molecules  have  now  been  identified  in  the 
hemidesmosome including  a  human autoantigen of 180 
kD  and the  extracellular matrix receptor et6lM integrin 
(Jones et al., 1994). Evidence for their roles in adhesion 
comes from studies where antibodies directed against their 
extracellular domains are capable of inducing a disruption 
of cell connective tissue adherence (Kurpakus et al., 1991; 
Liu et al., 1993). 
The  180-kD hemidesmosomal  autoantigen  was  first 
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identified using human autoantibodies from the serum of 
patients with a blistering skin disease called bullous pem- 
phigoid (BP)  1 (Labib et al., 1986; Klatte et al., 1989). For 
this reason it has been called the 180-kD bullous pemphi- 
goid antigen or BP180. Using BP autoantibodies, cDNAs 
that encode human BP180 have been isolated and its en- 
tire coding sequence has now been characterized (Giudice 
et al., 1991, 1992; Hopkinson et al., 1992). BP180 is trans- 
membranous and is inserted into the membrane of the 
hemidesmosome in a type II orientation (Hopkinson et al., 
1992). In other words, the collagen-like domain of BP180 
is extracellular while its NH2 terminus is located in the cy- 
toplasmic  plaque of the hemidesmosome (Hopkinson et 
al., 1992). The COOH terminus of BP180 contains a series 
of collagen-like repeats, leading some to classify BP180 as 
collagen type XVII (Giudice et al., 1991; Li et al., 1993). 
With the exception of a hemidesmosomal component of 
300 kD that binds keratin and may play a role in cytoskele- 
ton anchorage to the hemidesmosomal plaque, we know 
1. Abbreviation used in this paper. BP, bullous pemphigoid. 
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some elements (Jones et al., 1994; Skalli et al., 1994).  Fur- 
thermore, because of the inherent insolubility of hemides- 
mosomes  and  their  lack  of  abundance  in  tissues,  few 
hemidesmosome elements have been purified (Klatte and 
Jones, 1994).  Consequently, we have turned to molecular 
genetics for characterization of protein interactions within 
the hemidesmosome. In this study we have concentrated 
on analyses of BP180. Our investigations are possible be- 
cause we have made use of a cell line (804G) that assem- 
bles hemidesmosomes in vitro as well as several other cell 
lines, selected because they fail to express BP180 while ex- 
pressing  one  or  more  of  the  other  components  of  the 
hemidesmosome (Riddelle et al., 1991).  During the course 
of our experiments we have identified two functionally im- 
portant  domains  in  the  BP180  molecule  and  we  present 
evidence for an interaction between BP180 and the ct6 in- 
tegrin subunit. 
Materials and Methods 
Cell Culture 
804G and FG cells  were maintained in culture as reported previously 
(Riddelle et al.,  1991; Hopkinson and Jones,  1994). HT1080  cells were 
purchased from the American Tissue Culture Collection (ATTC, Rock- 
ville,  MD)  and maintained in Minimum Essential Medium  containing 
10% fetal calf serum, 100 IU/ml  penicillin, 100 ~.g/ml streptomycin (Sigma 
Chemical Co., St. Louis, MO). The hybridoma line 9El0, purchased from 
ATCC, was maintained in RPMI medium containing 10% fetal calf serum 
and 100 IU/ml penicillin,  100 Ixg/ml streptomycin. 
Antibodies 
A rabbit antiserum and monoclonal antibodies against the NH2 terminus 
of BP180  were  described in Hopkinson et al.  (1992).  9El0 antibodies 
against c-myc were collected as supernatant from subconfluent dishes of 
the 9El0 hybridoma line. A 134 integrin monoclonal antibody (3El) was 
purchased from GIBCO BRL (Gaithersburg, MD). The rat mAb 135-13C 
against a6 integrin was provided by Dr. Stephen Kennel (Oak Ridge Na- 
tional Laboratory, Oak Ridge, TN). GoH3 rat monoelonal antibody was 
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Figure 1.  Diagram  of mutant BP180 constructs. D1  consists of 
the entire cytoplasmic, membrane spanning (TM) and a portion 
of the noncollagenous extracellular (EC) domains of BP180 (res- 
idues 1-520)(Hopkinson et al.,  1992; Li et al., 1993). The amino 
acid  sequences  (1-36  [MDVTKKNKRDGTEVTERIVTETVT- 
TRLTSLPPKGGT]  and 494-520  [RKLKARVDELERIRRSIL- 
PYGDSMDRI])  were deleted from D1 to produce D1-36N and 
D1-27C,  respectively. The c-myc epitope (shaded) is present at 
the NH2 terminus of all three constructs. 
purchased from Immunotech (Westbrook, ME). Affinity-purified rabbit 
antibodies  against  ct6  integrin  were  provided  by  Dr.  Vito  Quaranta 
(Scripps Research Institute). A 134 polyclonal antibody was a gift from Dr. 
Martin Hemler (Dana-Farber Cancer Institute, Harvard Medical School, 
Boston,  MA).  Human  monoclonal  antibodies  (5E)  against  BP230,  a 
plaque component of the hemidesmosome, were provided by Dr. T. Hash- 
imoto, (Keio University, Tokyo, Japan) (Hashimoto et al., 1993). 
DNA Transfections 
804G, FG and HT1080 cells were maintained for 24 h on 22-mm glass cov- 
erslips. 804G cells were transfected with 10 p,g of plasmid DNA using the 
calcium phosphate protocol detailed in Sambrook et al.  (1989). FG and 
HT1080 cells were transfected with 3 p,g of DNA using Lipofectin reagent 
(GIBCO BRL). At 24 h after transfeetion ceils were harvested for immu- 
noblotting or processed for immunofluorescence microscopy. 
Constructs for Transfection Analyses 
The 134 integrin subunit cDNA, cloned into pBJ/neo plasmid vector was 
the kind gift of Dr. Vito Quaranta (Tamura et al., 1990). 
Truncated BP180 cDNAs were constructed using sequences encoding 
amino acids  1-520  of the published BP180  sequence (Hopkinson et al., 
1992; Li et at,,  1993). The methionine start site of BP180 that was pre- 
dicted by Hopkinson et al. (1992) has been confirmed by Li et aL (1993). 
To generate fragments D1  and DI-36N,  PCR was  used to amplify se- 
quences contained within a phage clone (M80) containing a 1620-bp cDNA 
Figure2.  Dl-transfected 804G cells were processed for double label immunofluorescenee using 9El0 antibodies against a c-myc epitope 
tagged to D1 protein (a) and anti-BP230 5E antibodies (b). 9E10 antibodies produce a cat-paw, punctate stain concentrated along the 
basal aspect of the transfected cell in a. There is colocalization of this stain with that generated by the 5E antibodies in the same cell 
shown in b. The z-section in the inset in a was prepared from the region indicated by the large white arrows. The arrow in the inset indi- 
cates the position of the substrate. The phase image of the cells is shown in c. Bar, 25 wm. 
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D1-36N  was  processed  for  immunofluores- 
cence using 9E10  antibodies  (a).  A  z-section 
of the  region  between  the  arrows  in  one  of 
the transfected cells in a  is shown in the inset. 
The  arrow  in  the  inset marks the  substrate. 
Note that the 9E10 antibodies primarily stain 
the apical surface of the cell The phase image 
of the cells is shown in b. Bar, 25 Ixm. 
that encodes these 520 amino acids as well as some of the 5' BP180 non- 
translated region. D1 and D1-36N had the same 3' end generated by PCR 
using primer (P1) corresponding to sequences between bp 1539 and 1561 
of h180. The 3' end of the P1 primer was modified to contain a BamHI site 
to facilitate subcloning. To prepare the D1 construct that encodes amino 
acids 1-520, a 5' primer, corresponding to -20 to -1 bp of h180 and the 
common 3' primer P1 were used to generate a 1581-bp PCR product. To 
prepare D1-36N, a 5' primer corresponding to bp 110 to 130 of ~180 and 
primer P1 were used to generate a PCR product lacking the sequence that 
encodes amino acids 1-36 of BP180. All fragments were subcloned into 
Bluescript KS+ (Stratagene, La Jolla, CA) that contained sequences en- 
coding 11 residues of the c-myc polypeptide recognized by the monoclonal 
antibody 9E10. This plasmid was obtained from Dr. Norman Karin (De- 
partment of Physiology, University of Texas, Houston, TX). 
D1-27C was prepared from the c-myc/D1 plasmid by PCR, using the T3 
primer that recognizes vector sequences 5' to the insert and a 3' primer 
corresponding to bp 1454 to 1479 of the coding sequence of the D1 cDNA. 
After  amplification, the  fragment was digested with  HindIII  and  sub- 
cloned into pRC/CMV (Invitrogen). The vector was prepared by first di- 
gesting with XbaI, followed by treatment with Klenow to produce blunt 
ends, and then digesting with HindIII. 
All constructs were sequenced according to standard procedures to en- 
sure that reading frame and orientation were correct. 
Immunofluorescence 
Cells on coverslips were fixed for 1 min in 3.7% formaldehyde in PBS and 
then extracted for 2 min in -20°C acetone. After air drying the ceils were 
processed for  single and  double  label  immunofluorescence as  detailed 
elsewhere (Jones and Goldman, 1985; Riddelle et al., 1991).  Some cover- 
slip preparations were rinsed in PBS and subsequently incubated in anti- 
body at 37°C for 30 min. After extensive washing the cells were fixed in 
3.7% formaldehyde in PBS and then incubated with the appropriate con- 
jugated secondary antibody. Cells on coverslips were viewed in an LSM10 
confocal microscope fitted with lasers and filters appropriate for the imag- 
ing of fluorescein and rhodamine (Carl Zeiss, Thornwood, NY). Images 
were stored on optical disc. 
Gel Electrophoresis, lmmunoblotting, 
and Immunoprecipitations 
Cell populations were solubilized in 8 M urea, 1% SDS, 10 mM Tris-HC1, 
pH 6.8, 10% I~-mercaptoethanol. Protein concentrations were determined 
using a Bio-Rad assay kit (Bio-Rad Labs., Richmond, CA). Some samples 
were processed for SDS--polyacrylamide gel electrophoresis on 7.5% acryl- 
amide slab gels according to Laemmli (1974). For analyses of low molecu- 
lar mass proteins, samples were run on 15% slab gels. Approximately 10 
p~g of protein was loaded per gel lane. Separated proteins were transferred 
to nitrocellulose (Towbin et al., 1979). The nitrocellulose sheets were pro- 
cessed for immunoblotting as detailed in Zackroff et al. (1984). In immu- 
noblotting analyses of immunoprecipitates, nitrocellulose bound antibody 
was detected with protein A  conjugated horse radish peroxidase (Zymed 
Labs., San Francisco, CA). 
For  immunoprecipitations, HT1080  cells  were  metabolically labeled 
with [35S]methionine for 3 h  at 37°C, washed in PBS, then lysed in TBS, 
pH 7.4, containing 1% Triton X-100, 2 mM CaC12. 1 mM PMSF, 100 M 
leupeptin, and 1 M  pepstatin. The lysate was centrifuged to remove cell 
debris and the supernatant was precleared with anti-rat IgG agarose beads 
(Sigma) for 1 h  at 4°C. After centrifugation to remove the beads, the su- 
pernatant was incubated with the ct6 mAb GoH3 at 4°C with rotation for 
2 h. Anti-rat IgG agarose beads were added and the incubation continued 
for 2 h more. After several washes with washing buffer (TBS with 1% Tri- 
Hopkinson et al. BPI80 and the Hemidesmosome  119 Figure 4.  804G cells were transfected with D1-27C and then pre- 
pared for double label immunofluorescence  using 9El0 (a) and 
5E (b) antibodies.  There is a punctate basal stain  in the trans- 
fected cell in a (a z-section  of the region between the arrows is 
shown in the inset in a where the substrate is marked by an ar- 
row). 5E antibodies  also produce a punctate stain  concentrated 
along the basal aspect of the ceils (b). However, 9El0 staining in 
a is concentrated in the perinuclear region where there is minimal 
5E antibody reactivity (b). (c) Phase image of the cells. Bar, 25 la,m. 
ton X-100) the pelleted beads were resuspended in SDS-PAGE sample 
buffer, under reducing conditions, and boiled for 3 min. Samples were 
electrophoresed on a 7.5% polyacrylamide  gel and processed either for 
immunoblot analysis or dried on a slab dryer and then exposed  overnight 
to X-OMAT  AR film (Kodak,  Rochester. NY). 
Results 
BPI80 Deletion Constructs for Transfection 
We have prepared a series of constructs encoding various 
portions  of  BP180.  Those  described  in  this  study  are 
shown diagrammatically in Fig. 1. One construct (D1) en- 
codes the entire cytoplasmic domain of BP180,  its mem- 
brane spanning region as well as an additional 30 extracel- 
lular  amino  acids  (residues  1-520)(Li  et  al.,  1993).  D1 
lacks the collagen domains of the wild-type molecule that 
begin at residue 568 (Li et al., 1993).  Two other constructs 
have been used. D1-36N eDNA is identical to D1 except 
that  it  is  missing  the  region  that  encodes  residues  1 
through 36 at the NH2 terminus of BP180. D1-27C lacks 27 
amino acids that are located at the COOH terminus of D1 
(residues  494-520).  All  constructs  were  tagged  at  their 
NH2 terminus with sequence encoding the c-myc epitope. 
It should be noted that we have tested constructs with 
other COOH- and NHE-terminal deletions of D1  (for ex- 
ample, Dl-133N) in the transfection assays to be detailed 
below. However, constructs with more extensive deletions 
in the 5' or 3' end produce protein that either remains dif- 
fusely localized in the cytoplasm or failed to polarize cor- 
rectly in the membrane (not shown). D1-27C and D1-36N 
represent the  minimal deletions  in  each terminus  of D1 
that give obvious phenotypes in our in vivo experiments. 
Identification  of Two Functionally Important 
Domains in BPI80 
For our initial  studies we used 804G cells that  assemble 
hemidesmosomes  in  vitro  (Riddelle  et  al.,  1991).  Since 
804G  cells possess  endogenous  BP180  protein,  we  used 
9E10  antibody that  recognizes the  c-myc epitope tag on 
transfected  protein  to  distinguish  transiently  expressed 
protein from wild-type BP180. The fate of the transfected 
protein  was  assessed  by confocal laser  scanning  micros- 
copy and its localization compared with a 230-kD protein 
component of the hemidesmosomal plaque that is recog- 
nized by the human monoclonal antibody 5E (Hashimoto 
et al., 1993).  All images show focal planes close to the site 
of cell-substrate interaction. In some instances, computer 
generated z-sections of cells are presented. 
In 804G cells transfected with the construct coding D1 
eDNA, mutant BP180 protein shows a polarized basal dis- 
tribution in a cat-paw pattern (Fig. 2). Moreover, the mu- 
tant  protein  is  polarized  and  codistributes  with  BP230 
along regions of cell-substrate interaction  (Fig.  2, inset). 
This  cat-paw  pattern  for  BP230  has  been  described  in 
804G  cells by several groups  (Riddelle  et  al.,  1991;  Spi- 
nardi et al., 1993; Jones et al., 1994).  In contrast, D1-36N 
mutant protein that lacks the 36 NH2-terminal most amino 
acids of the cytoplasmic domain of BP180 polarizes to the 
apical  surface  of  transfectants  (Fig.  3).  Furthermore,  it 
fails to associate with BP230 (result not shown). 
In  804G  cells  transfected  with  the  D1-27C  construct, 
mutant  BP180  protein  localizes  at  the  basal  aspect  of 
transfected  cells  in  a  punctate  manner  (Fig.  4 b, inset). 
However, it fails to codistribute with BP230 (Fig. 4). 
As  controls  for the  above studies,  we  have confirmed 
that the transfected 804G cell populations are expressing 
the appropriately sized tagged mutant proteins by western 
blotting using 9E10. Proteins close to their predicted mass 
of 58, 53, and 54 kD are recognized by 9E10 antibodies in 
whole  cell  extracts  of  D1,  D1-36N,  and  D1-27C  trans- 
fected 804G cell populations respectively (Fig. 5 A). 
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81MG cell populations trans- 
fected with D1 (lane 1), D1- 
36N  (lane  2),  D1-27C  (lane 
3), and mock transfected con- 
trois (lane 4) were processed 
for immunoblotting after 15% 
SDS-PAGE using 9El0 anti- 
bodies.  Note  that  the  9E10 
antibodies  recognize  tagged 
polypeptides close to their pre- 
dicted  masses of 58, 53, and 
54 kD in lanes 1-3, respectively, but fail to recognize  any proteins in lane 4. (B) Extracts of 804G (lane 1), FG (lane 2), and HT1080 
(lane 3) cells were processed for immunoblotting using J17 rabbit antibodies after 7.5% SDS-PAGE. The antibodies  recognize  only a 
180-kD polypeptide in lane 1. (C) Mock transfected (lane 1) and D1 transfected (lane 2) FG cells were processed for immunoblotting 
using J17 antibodies  after 15% SDS-PAGE. Note the 58-kD reactive polypeptide in lane 2. (D) Extracts of HT1080 cell populations 
transfected with D1 (lane 1), D1-36N (lane 2), D1-27C (lane 3), and mock transfected controls (lane 4) were processed for immunoblot- 
ting after 15 % SDS-PAGE using J17 antibodies. Note that the antibodies recognize polypeptides close to their predicted weights of 58, 
53, and 54 kD in lanes 1-3, respectively, but fail to recognize any proteins in lane 4. (E) Extracts of FG (lane 1), 134 integrin transfected 
HT1080 (lane 2) and mock transfected HT1080 (lane 3) cells were processed for immunoblotting using a 134 rabbit antiserum. Note that 
the 134 integrin  antibodies  recognize  a 200-kD protein in lanes i  and 2 while they fail to recognize polypeptides in lane 3. Circles on A 
and C and dashes on D denote standards of 66, 45, 31, 21.5, and 14.5 kD. Circles on B and E indicate 200, 116, and 97 kD. 
Since amino acid deletions in the cytoplasmic domain of 
BP180 might change its membrane topology from a type II 
to a type III orientation, as is the case for NH2-terminally 
mutated paramyxovirus HN polypeptide, we also assessed 
whether  mutant  BP180  NH2-terminal  domains  could  be 
detected extracellularly by incubating fixed but unperme- 
abilized cells with 9E10 (Parks and Lamb, 1993).  Unper- 
meabilized D1,  D1-27C,  and  D1-36N  804G transfectants 
were not recognized by 9El0 antibodies indicating that the 
deletions that we made had no impact on membrane to- 
pology of the transfected proteins (result not shown). 
D1 Protein Colocalizes with a6f14 Integrin in FG cells 
FG cells are derived from a human pancreatic carcinoma 
and possess the hemidesmosome associated integrin a6134 
(Tamura  et  al.,  1990).  This  integrin  heterodimer  shows 
basal  polarization  and  is  concentrated  in  streaks  and  in 
rows of spots towards the edge of the cells (Tamura et al., 
1990). Unlike 804G cells, FG cells do not express BP180 or 
BP230 as determined both by immunoblotting and by im- 
munofluorescence (Hopkinson and Jones, 1994; Fig. 5 B). 
To determine whether D1 protein is able to associate with 
a6B4  integrin  in  the  absence  of BP230,  we  transfected 
them with the construct containing the D1  cDNA.  Since 
9E10 recognizes endogenous c-myc in FG cells, we used an 
antiserum (J17)  that we have generated against the NH2 
terminus of BP180 to assess expression of D1  protein in 
the transfected cells by immunoblotting and immunofluo- 
rescence  (Hopkinson et  al.,  1992).  J17  antibodies  recog- 
nize a  58-kD polypeptide in the transfected FG cells but 
fail to recognize any proteins in vector alone transfected 
cells (Fig. 5 C). Furthermore, D1 polarizes in FG cells and 
appears concentrated  along the basal surface of FG cells 
Figure 6.  FG cells transfected with D1 were processed for double label immunofluorescence using an NH2-terminal monoclonal BP180 
antibody (Hopkinson et al., 1992)(a) and a 134 integrin rabbit antiserum (b). Note that both antibody preparations generate similar stain- 
ing patterns.  (c) Phase contrast image. Bar, 25 ~m. 
Hopkinson  et al. BP180  and the Hemidesmosome  121 Figure 7.  Double label immunofluorescence was performed on HT1080 cells transfected with D1 using J17 antiserum against the NH2 
terminus of BP180 (a) and rat mAb against the a6 integrin subunit (b). The solid arrows indicate colocalization of D1 protein and et6 
while the open arrow indicates a region of c~6 staining in a nontransfected cell. (c) Phase contrast image. Bar, 25 Izm. 
towards  the  cell  periphery.  Indeed,  the  D1  protein  pri- 
marily codistributes with 134 integrin (Fig. 6). 
D1 Protein Colocalizes with a6fll Integrin in 
HTI080 Cells 
HT1080  cells  express  the  integrin  heterodimer  tx6131 but 
not oL6134 and fail to express endogenous BP180 (Lin et al., 
1993;  Fig.  5,  B  and  E).  In  HT1080  cells,  ct6  localizes  in 
patches towards the edges of cells (Fig. 7 b). We have ob- 
served this same pattern of distribution using two rat mono- 
clonal  (GoH3  and  135-13C)  and  affinity-purified  rabbit 
antibodies against et6. 
The  fate  of  D1,  D1-36N,  and  D1-27C  mutant  BP180 
proteins was evaluated in HT1080 transfected cells by im- 
munofluorescence.  Since  HT1080  cells fail to express en- 
dogenous  BP180,  we  could  use  our  antibodies  directed 
against  the  NH2 terminus  of BP180  to detect  transfected 
protein.  In D1 HT1080 transfectants processed for double 
labelling,  D1  protein  colocalizes  with  the  or6 (Fig.  7).  To 
satisfy ourselves that the localization of D1 was consistent 
with  its  interacting  with  or6  integrin  we  also  transfected 
HT1080 cells with a vector encoding full length human 134 
integrin. The latter is known to preferentially bind et6 inte- 
grin in 131 integrin-containing  cells (Giancotti et al., 1992). 
In 134 integrin  HT1080  transfectants,  the  transfected  pro- 
tein associates with et6 integrin  in an identical  manner  to 
that observed in the D1 transfected ceils (Fig. 8). 
In contrast to both D1 and 134 integrin, D1-36N and D1- 
27C proteins  do not associate with oL6 integrin  in HT1080 
cell transfectants  (Figs. 9 and 10). Rather,  as is the case in 
804G  cells,  D1-36N  protein  polarizes  apically in HT1080 
cells while D1-27C shows a punctate stain along the entire 
basal aspect of transfected  cells  (Figs.  9  and  10). To con- 
firm expression of mutant protein in the transfected HT1080 
cells, immunoblotting was undertaken  (Figs. 5, D  and E). 
D1 Protein Coimmunoprecipitates with a6 
in HTI080 Cells 
To more rigorously examine the possibility of an associa- 
tion  between  BP180  and  a6  containing  integrin  hetero- 
Figure 8.  HT1080 cells, transfected with the 134 integrin subunit, were processed for double label immunofluorescence using 3E1 anti- 
bodies against 134 integrin (a) and rat monoclonal antibodies against ct6 (b). Note the colocalization of the two proteins. (c) Phase con- 
trast image. Bar, 25 ixm. 
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immunofluorescence  using J17 antibodies  (a).  A z-section (be- 
tween solid arrows) illustrating  apical polarization  of the trans- 
fected protein is shown in the inset in a. In the inset the substrate 
is marked by the arrow. (b) Phase contrast image. Bar, 25 ~m. 
dimers, coprecipitation analyses using HT1080 transfected 
cells  were  undertaken.  HT1080  ceils  transiently  trans- 
fected with D1  and  D1-27C were incubated in  [aSS]me- 
thionine-supplemented media. After 3 h, cells were lysed 
and processed for immunoprecipitation using the or6 rat 
mAb GoH3 as described in Materials and Methods. Sam- 
ples were separated by SDS-PAGE and either transferred 
to  nitrocellulose, or  dried  and  exposed  to  radiographic 
film. As  shown in Fig.  11,  GoH3 precipitates the heavy 
chain of et6 integrin migrating at 125 kD from reduced ex- 
tracts  of  both  D1  and  D1-27C  HT1080  transfectants. 
When  these samples were analyzed by Western blotting 
using the anti-BP180 serum J17, a single polypeptide of 58 
kD is detected in the immunoprecipitate of the D1 trans- 
fected cells whereas J17 antibodies show no reactivity with 
the precipitate prepared from D 1-27C transfectants. 
Discussion 
BP180 possesses the classic properties of a  cell adhesion 
molecule.  It  localizes to  the  cell surface  and  antibodies 
against its external domain perturb epidermal cell adhe- 
sion (Klatte et al., 1989; Hopkinson et al.,  1992; Liu et al., 
1994). BP180 is, however, an unusual protein not only in 
that it is a hybrid collagen but also because of its type II 
orientation in the plasma membrane (Giudice et al., 1991, 
1992; Hopkinson et al., 1992). 
We have used molecular genetics to characterize impor- 
tant functional domains within BP180. 804G cell transfec- 
tion data reveal that there is sufficient "information" en- 
coded  in  the  sequence  of  a  polypeptide  we  term  D1, 
comprised  of  the  cytoplasmic  and  transmembrane  do- 
mains as well as a short extracellular stretch of 30 residues 
of BP180, for its targeting to membranes, for its polariza- 
tion  within  the  cell  surface  and  for its  association with 
other hemidesmosomal elements such as BP230 and the 
et6134 integrin heterodimer. The collagen-like sequences of 
BP180 are not required for these properties of BP180. 
To map potential membrane targeting domains and pro- 
tein-protein interaction sites within D1, we made a series 
of deletions and expressed them in 804G cells. When the 
NH2-termina136 residues of D1 are removed, D1-36N pro- 
tein becomes concentrated in the apical cell membrane in 
both 804G and HT1080 transfectants. This indicates that 
the NH2-termina136-amino acid cytoplasmic tail of BP180 
is necessary for its correct basal polarization. In this re- 
gard, it is interesting to note that Kundu and Nayak (1994) 
have recently shown that the cytoplasmic tail of another 
type II protein, namely, the human transferrin receptor, 
also possesses a  membrane baso-lateral targeting signal. 
The importance of the NH2 terminus of type II proteins in 
membrane localization is  also seen in  a  recent study by 
Parks and Lamb (1993) who have shown that the cytoplas- 
mic domain of the type II membrane protein, paramyxovi- 
rus HN polypeptide, determines protein topography in the 
membrane. However, we emphasize that BP180 is  quite 
distinct from these other type II proteins. Firstly BP180 
possesses an extensive cytoplasmic domain of 400 amino 
acids while  the  paramyxovirus HN polypeptide and  the 
transferrin receptor have only short cytoplasmic domains 
consisting of 17  and  61  amino  acids,  respectively. Also, 
BP180 is also a component of a large macromolecular en- 
tity that shows basal membrane polarization. Thus, there 
are far more restraints on BP180 than on both the para- 
myxovirus HN polypeptide and transferrin receptor with 
regard to its membrane localization. 
In contrast to D1-36N, D1-27C protein, where the extra- 
cellular noncollagenous COOH-terminal most 27 residues 
of D1 are removed, can be detected along sites of cell-sub- 
strate interaction in 804G cells i.e., is correctly polarized. 
However, D1-27C fails to colocalize with other hemides- 
mosomal elements such as BP230. Indeed, these 27 extra- 
cellular amino acids of BP180, a  highly charged domain 
containing eight basic and six acidic residues, would appear 
to be an important site of extracellular interaction between 
BP180 and other components of the hemidesmosome. 
To identify candidate molecules that could interact with 
BP180, we made use of two cell lines that fail to express 
one  or more  of the  known  components of hemidesmo- 
somes. In particular, we used FG cells, which lack BP230 
and BP180, and HT1080 cells, a fibrosarcoma line, which 
lack not only BP230 and BP180, but also the [~4 integrin 
subunit (Lin et al., 1993; Hopkinson and Jones, 1994). Yet 
despite these deficiencies, in both FG and HT1080 cells, 
D1 protein clearly colocalizes with the or6 integrin regard- 
less of its 13 partner. Moreover, D1 protein coprecipitates 
with the a6 integrin subunit in HT1080 transfectants sug- 
gesting the possibility that BP180 may bind tx6 integrin. 
Since D1-27C fails to colocalize with et6 integrin in all the 
cell types we have analyzed even though it polarizes cor- 
rectly, we further speculate that BP180--a6 interaction oc- 
curs extracellularly. Of course, bear in mind that we cannot 
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a z-section generated between the arrows. The arrow in the inset shows the plane of the substrate. Note the basal concentration of fluo- 
rescence in the z-section. (b) Phase contrast image. Bar, 25 p~m. 
rule  out  that  this  interaction  may involve other proteins. 
Nonetheless,  to our knowledge  this would be the first de- 
scribed  extracellular  association  between  an integrin  het- 
erodimer and another membrane protein.  Whether this in 
some way modulates  a6134  integrin-ligand  binding  is  the 
object of our current studies. 
There is some circumstantial  support for an association 
between a6 and BP180 in another experimental system. In 
normal mouse skin a6134 integrin, BP180 and BP230 local- 
ize  to  the  basal  cell  epidermal-dermal  border  (unpub- 
Figure 11.  An autoradiograph 
of GoH3 immunoprecipitates 
of radiolabeled HT1080 cells 
transfected  with  D1  or  D1- 
27C is shown in panel A (lanes 
1  and 2,  respectively). Lane 
3  shows  a  control  immuno- 
precipitate  of  radiolabeled 
HT1080  D1  transfectants  in 
which the primary antibody, 
GoH3, was omitted.  A  125- 
kD  labeled  species,  corre- 
sponding to et6, is observed in lanes 1 and 2 only (arrow). Note 
that two radiolabeled polypeptides (arrow heads) are nonspecifi- 
cally precipitated in all three samples. The same three immuno- 
precipitates were processed for immunoblotting using antiserum 
J17, followed by horse radish peroxidase conjugated  goat anti- 
rabbit secondary antibody (B). Reactive species were visualized 
using chloro-L-naphthol substrate (Zackroff et al.,  1984). An ar- 
row marks a single reactive species of 58 kD in the D1 precipitate 
(lane 1). This species is absent in lanes 2 and 3. Dashed lines indi- 
cate molecular masses of 97, 66, and 45 kD. 
lished).  When  treated  with  retinoic  acid,  both  a6  and 
BP180  dramatically  reorganize  in  mouse  epidermis  and 
become  localized  suprabasally.  This  is  independent  of 
other  hemidesmosome  elements  such  as  134 integrin  and 
BP230  that  remain  restricted  to  the  epidermal-dermal 
border (Tennenbaum  T., A.  Mroz, A.  Belanger,  T. Wild- 
nauer,  J.  C.  R.  Jones,  and  J.  S.  Gordon.  1994.  J.  Invest. 
Dermatol. 102:555.). 
Spinardi et al. (1993). have also used 804G cells as a mo- 
lecular genetic system for studying hemidesmosomal pro- 
tein  interactions.  Their  results  suggest  some  interesting 
parallels between BP180  and the 134 integrin  subunit  with 
regard to both targeting of protein to the hemidesmosome 
as well as  134 association  with a6 integrin.  They analyzed 
sequences  of 134 integrin  that are required  for its incorpo- 
ration into the 804G cell hemidesmosomes.  As is the case 
for BP180, a specific stretch of 303 amino acids in the cyto- 
plasmic domain of 134 integrin is necessary for its incorpo- 
ration  into  hemidesmosomes  while  the  extracellular  do- 
main of 134 is apparently required  for interaction  with its 
obligate partner a6 (Spinardi et al., 1993). 
It is intriguing  to relate  our results  with  the  studies  of 
Liu  et  al.  (1993).  These  workers  generated  antibodies 
against  14 amino acids (residues  508-521)  in the extracel- 
lular  noncollagenous  region  (NCE  domain)  of  BP180 
(Giudice et al., 1993). Such antibodies induce disruption in 
epidermal  cell--dermis  interactions  in  neonatal  mice.  All 
but  one  of  these  amino  acids  (RSILPYGDSMDRI)  are 
contained within the 27-amino acid stretch of D1 that ap- 
pear necessary for a  BP180-a6  interaction.  Furthermore, 
over 60%  of BP sera contain  human  autoantibodies  that 
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(Giudice et al., 1993). Such autoantibodies are considered 
to be pathogenic i.e., capable  of inducing blistering that 
characterizes the disease. We speculate that such antibod- 
ies,  when  bound  to  BP180,  perturb  the  interaction  be- 
tween  BP180  and a6,  thereby inducing the hemidesmo- 
some to "fall apart." This would parallel the disruption of 
hemidesmosomes  seen  in  various  model  systems  where 
epithelial cells have been treated with antibodies that rec- 
ognize external domains of either the et6 or the ~4 integrin 
subunits (Kurpakus et al., 1991). 
In summary, we have used molecular genetics to identify 
two functionally important sequences within the noncol- 
lagenous domains of the BP180 molecule. The NH2-termi- 
nal sequence is involved in protein polarization while the 
COOH-terminal noncollagenous 27 amino acids is neces- 
sary  for  colocalization  with  other  hemidesmosomal  ele- 
ments.  Our studies  have  not only provided new insights 
into potential protein-protein interactions in the hemides- 
mosome but also indicate a potential mechanism for the 
pathogenesis of autoantibodies in a blistering skin disease. 
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